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to have emerged 70 million years ago (McGeoch and
Davison, 1999). Even with this ancient history, VZV has
long been considered to have a stable genome. The
complete DNA sequence (124,884 bp) was published by
Davison and Scott in 1986. The VZV genomic sequence
with its 69 open reading frames (ORFs) is frequently
cited, even for strains other than Dumas, with the pre-
sumption of identity. The recent discovery of a geneti-
cally variant virus has led us to reconsider the presump-
tion of VZV immutability (Santos et al., 1998). In the case
of VZV-MSP, we discovered a virus with a missense
mutation in a major glycoprotein called gE. Because this
point mutation eliminates a B cell epitope, we consider
this polymorphism to have been the likely end result of
an antibody selection in an infected human host (Grose,
1999). This mutant virus exhibited an accelerated cell-to-
cell spread phenotype in both infected cells and the
SCID-hu animal model of VZV infection (Santos et al.,
2000). Prior to this observation, all VZV wild-type isolates
and strains were considered to have a phenotype so
similar as to be indistinguishable.
Based upon its likely pathogenesis, VZV undergoes
only about 20 cycles of replication during primary infec-
tion (Grose, 2000); even though this period provides
limited opportunity for genetic diversification, some
changes obviously occurred to generate VZV-MSP.
Therefore, we postulated that a slowly coevolving VZV
genome could be investigated by a similar genetic ap-
proach as directed toward the human genome (Collins et
al., 1998). The Human Genome Project has concentrated
enormous effort over the past 3 years on the identifica-
1 To whom correspondence and reprint requests should be ad-
ressed at University of Iowa Hospital/2501 JCP, 200 Hawkins Drive,owa City, IA 52242. Fax: 319-356-4855. E-mail: charles-grose@
iowa.edu.
1tion of single nucleotide polymorphisms (SNPs), the most
common type of genetic variation. SNPs are sites that
contain single base pair variations (Collins et al., 1997,
1998). These sites generally are considered biallelic due
to the limited number of transversions that have been
found (Brookes, 1999). Each allele must occur in more
than 1% of the population to be considered an SNP
(Kruglyak et al., 1997; Wang et al., 1998). Individuals who
share many of the same SNPs are likely to have arisen
from a common ancestor and can therefore be grouped
by inheritance (Collins et al., 1997). Geneticists have
estimated that a comparison of the corresponding nucle-
otide sequences from as few as 8–10 individuals can
provide valuable information about the frequency and
location of SNPs (Collins et al., 1998; Wang et al., 1998).
To assess whether VZV-MSP represented a truly un-
usual VZV variant genome, we selected 10 geographi-
cally diverse VZV strains and isolates for this analysis.
VZV-MSP was isolated in Minnesota in late 1995 (Santos
et al., 1998). VZV-32 was isolated in Texas in the 1970s
(Grose, 1980). VZV-Oka was isolated in Japan and atten-
uated in the 1970s (Takahashi et al., 1975); the vaccine
virus was a gift from M. Takahashi. VZV-VSD was a
wild-type virus collected in South Dakota in the 1980s.
VZV-VIA was isolated in Iowa from a child with chicken-
pox in the 1990s. VZV-Iceland was isolated in Iceland
from vesicle fluid of a child with chickenpox in the 1990s.
VZV-Ellen was originally isolated in Georgia from a child
with chickenpox in the 1960s and obtained from the
American Type Culture Collection (Gershon et al., 1973).
VZV 80-2 was originally isolated in Pennsylvania from an
adult with herpes zoster in the 1980s (Ecker and Hyman,
1982). Two viral isolates, VZV-LAX1 and VZV-LAX2, were
collected in Los Angeles in the early 1990s, before the
introduction of varicella vaccine. The methods for VZV
propagation in cell culture, as well as the methods for
PCR amplification and DNA sequencing, have been de-
scribed in detail (Santos et al., 2000).
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2 MINIREVIEWVZV-MSP was sequenced at passage 8, VZV-32 at
passage 18, VZV-VSD at passage 5, VZV-VIA at passage
9, VZV-Iceland at passage 9, VZV 80-2 at passage 10,
VZV-LAX1 and VZV LAX2 at passage 6, VZV-Ellen at
passage .100, and VZV-Oka vaccine strain at passage
0. All sequences were compared with that of VZV-
umas (Accession No. XO4370); VZV-Dumas was iso-
ated in The Netherlands in the 1970s but its passage
istory was not detailed (Davison and Scott, 1986).
Six genes were sequenced in each of the 10 strains.
he noncoding and coding polymorphisms are listed in
able 1. The VZV gE gene was of particular interest
ecause of the recent discovery of the gE escape mutant
train VZV-MSP (Santos et al., 1998). Surprisingly, five gE
polymorphisms were found among the 10 tested strains
and isolates, 4 of which caused amino acid substitutions.
VZV-Ellen, VZV-Iceland, and VZV 80-2 had three identical
polymorphisms. One was a synonymous mutation within
codon 220 (bp 660). Two nonsynonymous mutations in
these three strains caused amino acid substitutions
within codons 40 (T3 I) and 536 (L3 I). VZV-LAX1 and
the vaccine strain VZV-Oka also contained the mutation
within codon 40 but lacked the other two mutations found
within VZV-Ellen, VZV-Iceland, and VZV 80-2. VZV-VSD
was the only strain tested which contained a polymor-
phism within the gE cytoplasmic domain of gE. Interest-
ingly, this change within codon 603 (G3 D) inserted an
dditional acidic amino acid adjacent to the acidic ca-
ein kinase II phosphorylation site of gE (Grose, 1990;
lson et al., 1997; Zhu et al., 1996). VZV-LAX2, VZV-32,
nd VZV-VIA were the only strains tested that did not
ontain gE substitutions when compared to the Dumas
train. Since the codon 150 (D–N) mutation previously
ound in VZV-MSP gE was not discovered in any other
train, VZV-MSP gE retained a unique sequence among
ll currently tested strains and isolates.
The glycoprotein genes B and L showed a remarkable
onsistency of sequence in that 8 of 10 strains were
dentical to VZV-Dumas (Davison and Scott, 1986). Only
ZV-Oka and VZV-LAX1 contained any polymorphisms
nd these polymorphisms were identical between the
wo strains. In gL, two changes were discovered; the first
ncluded the insertion of a methionine codon between
mino acids 9 and 10 (bp 27 and 28), which is of great
nterest because it may represent an alternative start
ite. Second, there was a G to A substitution at bp 319
when compared with VZV-Dumas) that resulted in the
onversion of an alanine to a threonine residue. These
ifferences together with the polymorphisms in the gI
nd gH genes are highlighted in Table 1.
The fact that polymorphisms were easily discernible in
he major glycoprotein structural genes led us to exam-
ne whether a similar situation existed in the major VZV
egulatory gene called IE62 (Perera et al., 1992, 1993;
oriuchi et al., 1994). Overall, 40 polymorphisms were
ound in the IE 62 gene of the 10 tested strains, when pompared to the VZV-Dumas IE 62 gene (Table 1). As
as the case with the gE and gH gene sequences,
ZV-Ellen, VZV-Iceland, and VZV 80-2 showed remark-
ble similarity in their IE 62 genes. VZV-Oka and VZV-
AX1 were similar to these 3 strains, as they shared the
ilent IE 62 substitutions within codons 61 (bp 183) and
29 (bp 387) but lacked the change at codon 1071 (bp
211). VZV-Oka shared additional polymorphisms with
ZV-Ellen at codons 341 (bp 1023) and 958 (R 3 G) that
ere not present in VZV-Iceland and VZV 80-2. VZV-Ellen
evealed eight unique substitutions in addition to those
hared with VZV-Iceland, VZV 80-2, and VZV-Oka. VZV-
ka and VZV-LAX1 exclusively shared four polymor-
hisms at codons 473, 509, 609, and 1274 (bp 1419, 1527,
827, and 3822, respectively).
Both VZV-32 and VZV-VIA contained identical polymor-
hisms within IE 62 at codons 516 (bp 1548), 1057 (Q 3
), 1072 (Q 3 R), 1080 (bp 3240), and 1241(S 3 G).
ZV-32 also contained five unique changes and the
958G mutation found in VZV-Ellen and VZV-Oka. VZV-
IA revealed four unique polymorphisms, which com-
ined with the unique changes within VZV-32 allowed
ifferentiation of VZV-32 and VZV-VIA. VZV-VSD contained
ne unique substitution (A3 V at codon 602) but other-
ise was identical to the Dumas strain. VZV-MSP as well
s VZV-LAX2 contained no IE62 polymorphisms, other
han the synonymous substitution found within codon 30
bp 90), when compared to the Dumas strain.
For completeness, transitions were compared with
ransversions. Mutations that result in the substitution of
pyrimidine for a pyrimidine or a purine for a purine are
alled transitions. Substitutions of a purine for a pyrimi-
ine and vice versa are transversions. Transversions are
uch less common than transitions in the human ge-
ome. When the numbers of transitions and transver-
ions were counted for the sequenced VZV genes, 77%
ere transitions. Interestingly, all three substitutions in
B were transversions. This result was in contrast with
he other genes. For example, the gE gene had 1 trans-
ersion and 4 transitions; the IE62 gene had 6 transver-
ions and 34 transitions.
The DNA encoding the structural glycoprotein genes
E, gH, gB, gI, and gL as well as the immediate early
ene 62 accounted for nearly 13,000 nucleotides. When
he complete nucleotide sequences for the aggregate
otal of 60 genes were compared with their counterparts
n the VZV Dumas strain, 61 polymorphisms were ob-
erved. Within the glycoprotein genes 21 polymorphisms
ere found, and within the IE62 gene 40 polymorphisms
ere found. A nucleotide difference found in only one
irus may be unique to that virus and not found in any
ther virus, i.e., it may not represent a SNP. For this
eport, therefore, only alleles found in at least two viruses
ere considered SNPs. In other words, even if 98 addi-
ional as yet unsequenced VZV genomes lacked this
articular change, it would still qualify as a SNP. Based
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4 MINIREVIEWupon these criteria, among all polymorphisms detected,
34 were considered SNPs.
As proposed in the Human Genome Project, shared
SNPs facilitate grouping by likely common ancestry. In
the human genome, all SNPs are considered to have
originated after divergence from the great apes but be-
fore the emergence of different human populations; by
the concept of coevolution of herpesviruses with human-
kind, therefore, VZV SNPs presumably emerged during a
similar period of geologic time (Brookes, 1999). When the
shared SNPs among the 10 VZV strains were tabulated,
any two viruses that shared at least 85% (29/34) SNP
genotypes were considered to be closely related. As can
be clearly seen, four groups have emerged by this anal-
ysis (Fig. 1). Of particular interest, the viruses from The
Netherlands, Iceland, and Japan segregated into differ-
ent groups. The VZV-Oka vaccine strain clustered with
one isolate from Los Angeles and presumably repre-
sented polymorphisms of Japanese/Asian ancestry. VZV-
Ellen, VZV-Iceland, and VZV 80-2 formed another group;
these viruses were isolated from Iceland and two states
along the Atlantic coast of the United States. VZV-32 and
VZV-VIA formed a third group from the central United
States. Of great relevance, VZV-MSP was most closely
related to the VZV-Dumas prototype strain and was in-
cluded in a fourth group along with VZV-VSD and LAX2;
this VZV group presumably originated from Northern Eu-
rope. Since the D150N change in the gE gene occurred
only in VZV-MSP, by our definition it was not a SNP. In
fact, it was most likely a rare contemporary mutation in
the VZV genome.
The SNP analysis facilitated the identification of “hot
spots” within individual ORFs (Wang et al., 1998). One
example, in particular, was gH, where an amino acid
substitution (P269L) was found within VZV-MSP gH. The
same gH P269L polymorphism was also detected within
most of the VZV strains tested. Because of this unex-
FIG. 1. Classification of VZV on the basis of SNP analysis. A polymor
this definition, a total of 34 SNPs were delineated after genotyping of s
at least 85% shared SNPs) are shown within the four boxes. The strains
GenBank accession numbers: VZV-MSP (AY005330-5), VZV-Ellen (AY01pected finding, we performed a BLAST peptide searchcoupled with MaxHomology alignment to assess which
amino acid was present in the homologous regions of gH
within other alphaherpesviruses (Fig. 2) (Rost, 1996;
Sander and Schneider, 1991; Karlin and Aschtul, 1993).
Interestingly, the substitution of leucine at codon 269 (or
its homolog) leads to greater identity with gH found in
different strains of pseudorabies virus as well as bovine
herpes virus type 1. Other alphaherpesviruses, including
herpes simplex virus, turkey herpes virus, and equine
herpes virus type 1, contained a proline at the homolo-
gous site. Simian varicella virus was the only strain
examined which did not express either a proline or
leucine at this site but instead contained a serine resi-
due. Therefore, a proline or leucine residue is present
within this site on the gH ectodomain not only within
different VZV strains but also within the homologous
region of many alphaherpesviruses (Fig. 2).
Finally, the VZV SNP analysis mimics human DNA in
that it was not predictable which viral ORF would exhibit
mutations (Collins et al., 1997; Wang et al., 1998). Under
certain circumstances, the absence of SNPs may sug-
gest a highly conserved essential function of the ORF.
For example, the low number of SNPs in the relatively
small gI or gL genes supported an earlier concept that
both gene products behave as chaperone proteins, gI
with gE and gL with gH (Duus and Grose, 1996; Mallory
et al., 1997). On the other hand, the large number of
polymorphisms within the 10 SNP profiles of IE62 was
remarkable. These data reaffirm the recent observations
by others that VZV-Oka vaccine strain IE62 exhibited
several polymorphisms (Argaw et al., 2000; Gomi et al.,
2000); our IE62 sequence differed in turn from those in
the other two publications. The data also emphasize that
wild-type strains exhibit IE62 polymorphisms not found in
VZV-Dumas. In this situation, SNP analysis is a powerful
tool by which to assess whether IE62 has a role in VZV
attenuation; presumably any IE62 polymorphism likely to
must be found in at least 2 of 10 strains to be called a SNP. Based on
rent ORFs of 10 VZV strains. Subgroups of VZV strains (as defined by
apan, Iceland, and The Netherlands segregated into different clusters.
), and VZV-32 (AF314215-21).phism
ix diffebe involved in attenuation would be unique to VZV-Oka
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5MINIREVIEWvaccine IE62 and not present in any wild-type strain, i.e.,
the polymorphism would not be a SNP (Table 1). Inter-
estingly, SNP analysis in the human genome suggests
that polymorphisms with C7 T substitutions may reflect
potential cytosine methylation sites, since cytosine res-
idues within CpG dinucleotides are the most mutable
sites within the human genome (Wang et al., 1998). CpG
methylation certainly remains an unexplored mechanism
in a VZV regulatory gene.
Furthermore, the SNP data may be relevant to VZV
pathogenesis. Within the human genome, one SNP in
one gene can serve as a marker for a specific genetic
disease. By extension, the VZV SNP data indicated a
genetic potential for an occasional emergence of a wild-
type virus with polymorphisms which either increase
virulence or delete B or T cell epitopes present in the
vaccine virus. In this regard, it is noteworthy to point out
that the VZV-MSP virus is called an escape mutant be-
cause it lacks an epitope found in the gE virion surface
protein of most wild-type strains as well as the vaccine
strain VZV-Oka. Likewise, the mutable IE62 protein is
known to harbor T cell epitopes which remain largely
unmapped; these epitopes could include a SNP (Arvin et
l., 1986; Bergen et al., 1991). As part of this SNP analy-
is, the discovery that two randomly selected VZV iso-
ates from Los Angeles differed considerably in their SNP
rofiles (Table 1 and Fig. 1) suggested a very heteroge-
eous VZV population in the Los Angeles area. There-
ore, we recommend SNP analysis during unexpected
uture outbreaks of chickenpox (Buchholz et al., 1999), in
rder to better define the viral genotype.
In summary, SNP analysis of the VZV genome provides
n alternative approach to more traditional phylogenetic
nalysis. In fact, when a VZV evolutionary tree was con-
tructed using the IE62 gene sequences, the phylogram
Fig. 3) was remarkably similar to the SNP groupings in
ig. 1. The SNP data and GrowTree program not only
FIG. 2. Comparison of VZV gH at codon 269 to homologous gH regi
performed at the Predict Protein Website (Columbia University, http://do
at codons 269–270 was compared to the homologous region on the
contained either a proline or leucine at the homologous Pro269 codon o
virus; hsve4 and hsveb, equine herpes virus; hsvbc, bovine herpes virus
virus; hsvtu, turkey herpes virus.erify that VZV has continued to evolve in the 20th cen-tury but also document a previously unappreciated but
intriguing genetic diversity of this reclusive human her-
pesvirus. For example, detection of one or two SNPs of
the entire 124,884-bp genome now appears sufficient to
other alphaherpesviruses. Blast peptide and MaxHom searches were
c.columbia.edu/predictprotein/). The VZV gH proline–proline sequence
lphaherpesviruses. Note that all strains except simian varicella virus
H. VZV-MSP and vzvd, varicella-zoster virus; ch25806, simian varicella
prvn3, and prvka, pseudorabies virus; hsvle and hsv11, herpes simplex
FIG. 3. Evolutionary analysis of the VZV IE62 gene. An evolutionary
tree was generated using neighbor-joining analysis within the
GrowTree program supplied by Genetics Computer Group, University ofons of
do.cpm
listed a
f VZV gWisconsin (Madison, WI). The Jukes–Cantor method was selected for
distance correction.
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6 MINIREVIEWclassify VZV into subgroups. In this regard, identification
of biologically important VZV SNPs and hot spots will
facilitate the incorporation of relevant oligonucleotides
into biochips for rapid microarray analysis of VZV muta-
tions within large viral populations (Brown et al., 1999;
hu et al., 1998). Based upon our experience with VZV-
SP and these SNP analyses, we predict the discovery
f additional VZV genotypes with distinguishable pheno-
ypes.
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